- Home
- JAZZ vs BPOP Comparison
JAZZ vs BPOP Comparison
Compare JAZZ & BPOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- BPOP
- Stock Information
- Founded
- JAZZ 2003
- BPOP 1893
- Country
- JAZZ Ireland
- BPOP United States
- Employees
- JAZZ N/A
- BPOP N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- BPOP Major Banks
- Sector
- JAZZ Health Care
- BPOP Finance
- Exchange
- JAZZ Nasdaq
- BPOP Nasdaq
- Market Cap
- JAZZ 7.9B
- BPOP 7.8B
- IPO Year
- JAZZ 2007
- BPOP N/A
- Fundamental
- Price
- JAZZ $136.58
- BPOP $125.64
- Analyst Decision
- JAZZ Strong Buy
- BPOP Buy
- Analyst Count
- JAZZ 14
- BPOP 7
- Target Price
- JAZZ $179.21
- BPOP $128.71
- AVG Volume (30 Days)
- JAZZ 758.5K
- BPOP 514.2K
- Earning Date
- JAZZ 11-05-2025
- BPOP 10-23-2025
- Dividend Yield
- JAZZ N/A
- BPOP 2.39%
- EPS Growth
- JAZZ N/A
- BPOP 44.82
- EPS
- JAZZ N/A
- BPOP 10.29
- Revenue
- JAZZ $4,086,695,000.00
- BPOP $2,799,129,000.00
- Revenue This Year
- JAZZ $5.70
- BPOP $0.07
- Revenue Next Year
- JAZZ $6.16
- BPOP $7.45
- P/E Ratio
- JAZZ N/A
- BPOP $12.22
- Revenue Growth
- JAZZ 4.52
- BPOP 8.02
- 52 Week Low
- JAZZ $95.49
- BPOP $78.23
- 52 Week High
- JAZZ $148.06
- BPOP $129.32
- Technical
- Relative Strength Index (RSI)
- JAZZ 63.56
- BPOP 52.87
- Support Level
- JAZZ $125.79
- BPOP $123.69
- Resistance Level
- JAZZ $140.39
- BPOP $129.10
- Average True Range (ATR)
- JAZZ 3.18
- BPOP 2.51
- MACD
- JAZZ 0.46
- BPOP -0.52
- Stochastic Oscillator
- JAZZ 71.59
- BPOP 29.31
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.